Shin Nippon Biomedical Laboratories, Ltd. had a revenue of 5.55B in the quarter ending Jun 30, 2024, with -34.45%. This bring the company's revenue in the last twelve months to 26.20B, Increased -0.97%. In the fiscal year ending Mar 31, 2024, Shin Nippon Biomedical Laboratories, Ltd. had annual revenue of 26.45B with 5.42% growth.